This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

HEXO 배당금 및 환매

배당금 기준 확인 0/6

HEXO 배당금을 지급한 기록이 없습니다.

주요 정보

n/a

배당 수익률

환매 수익률

총 주주 수익률	0%
미래 배당 수익률	n/a
배당금 성장	n/a
다음 배당금 지급일	n/a
전 배당일	n/a
주당 배당금	n/a
지급 비율	n/a

최근 배당금 및 환매 업데이트

업데이트 없음

Recent updates

Bearish: Analysts Just Cut Their HEXO Corp. (TSE:HEXO) Revenue and EPS estimates

Mar 21

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: 과거에 HEXO 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.

배당금 증가: HEXO 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.

시장 대비 배당 수익률

HEXO 시장 대비 배당 수익률

HEXO 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트	배당 수익률
회사 (HEXO)	n/a
시장 하위 25% (CA)	1.8%
시장 상위 25% (CA)	6.2%
업계 평균 (Pharmaceuticals)	2.4%
애널리스트 예측 (HEXO) (최대 3년)	n/a

주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 HEXO 의 배당 수익률을 평가할 수 없습니다.

고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 HEXO 의 배당 수익률을 평가할 수 없습니다.

주주에 대한 수익 배당금

수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 HEXO 의 지급 비율을 계산하기에는 데이터가 부족합니다.

주주에 대한 현금 배당금

현금 흐름 범위: HEXO 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.

This company has been acquired

HEXO 배당금 및 환매

배당금 기준 확인 0/6

주요 정보

최근 배당금 및 환매 업데이트

Recent updates

HEXO Corp.(NasdaqCM:HEXO) dropped from NASDAQ Composite Index

HEXO Corp. announced that it has received $25 million in funding

Consensus EPS estimates upgraded to CA$0.81 loss, revenue downgraded

New minor risk - Financial position

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

HEXO Corp. to Report Q3, 2023 Results on Jun 14, 2023

Price target decreased by 22% to CA$1.64

Price target decreased by 9.1% to CA$1.95

Consensus revenue estimates decrease by 27%, EPS upgraded

Bearish: Analysts Just Cut Their HEXO Corp. (TSE:HEXO) Revenue and EPS estimates

Price target decreased by 11% to CA$2.28

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

HEXO Corp. Launches Enhanced Inhalation Technology

HEXO Corp Wins Complete Dismissal of Putative Québec Shareholder Class Action

HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash Brands

Consensus revenue estimates fall by 17%

Price target decreased to CA$0.20

First quarter 2023 earnings: EPS and revenues miss analyst expectations

HEXO Corp., Annual General Meeting, Jan 31, 2023

Consensus EPS estimates fall by 12%

High number of new and inexperienced directors

Consensus EPS estimates fall by 12%

Consensus EPS estimates fall by 12%

Consensus forecasts updated

Full year 2022 earnings: EPS and revenues miss analyst expectations

Sundial Growers Inc. (NasdaqCM:SNDL) acquired Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

No longer forecast to breakeven

HEXO Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Price target decreased to CA$0.29

High number of new and inexperienced directors

HEXO Corp. has completed a Follow-on Equity Offering in the amount of $40 million.

Sundial Growers Inc. (NasdaqCM:SNDL) entered into a purchase agreement to acquire Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

HEXO Corp. Announces CFO Changes, Effective May 16, 2022

HEXO Corp. Announces to Close Its Belleville Facility and Transition Its Operations

Forecast to breakeven in 2024

High number of new and inexperienced directors

Consensus EPS estimates fall by 718%

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

High number of new and inexperienced directors

HEXO Corp. Announces Refreshed Board of Directors

HEXO Provides Nasdaq Listing Update

Olegna Holdings Inc acquired a 25% stake in Belleville Complex Inc from HEXO Corp. (TSX:HEXO) for $10.1 million.

High number of new directors

Consensus revenue estimates fall by 12%

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

HEXO Corp. Reports Impairment Charges for the First Quarter Ended October 31, 2021

The Consensus EPS Estimates For HEXO Corp. (TSE:HEXO) Just Fell Dramatically

Price target decreased to CA$2.61

High number of new directors

Director & Co-Founder Sebastien St-Louis has left the company

Independent Chairman of the Board recently bought CA$260k worth of stock

Full year 2021 earnings released: CA$0.90 loss per share (vs CA$7.06 loss in FY 2020)

Full year 2021 earnings released: CA$0.90 loss per share (vs CA$7.06 loss in FY 2020)

Price target decreased to CA$4.95

Price target decreased to CA$6.12

HEXO Corp. (TSX:HEXO) completed the acquisition of 48North Cannabis Corp. (TSXV:NRTH) from Canopy Growth Corporation (TSX:WEED), Wallington Investment Holdings Limited and others.

HEXO Corp. (TSX:HEXO) completed the acquisition of 9037136 Canada Inc. (“Redecan”) from Will Montour, Pete Montour and family.

Price target decreased to CA$7.61

Does HEXO (TSE:HEXO) Have A Healthy Balance Sheet?

Third quarter 2021 earnings released: CA$0.17 loss per share (vs CA$0.26 loss in 3Q 2020)

HEXO Corp. Reports Impairment of Property, Plant and Equipment for the Third Quarter Ended April 30, 2021

Price target decreased to CA$8.75

Consensus revenue estimates fall to CA$119.5m

HEXO Corp. Wins Dismissal of Ny State Court Shareholder Class Action

Forecast to breakeven in 2023

HEXO Corp. (TSX:HEXO) completed the acquisition of Zenabis Global Inc. (TSX:ZENA).

HEXO Corp. (TSX:HEXO) entered into a definitive agreement to acquire 9037136 Canada Inc. from Will Montour, Pete Montour and family for approximately CAD 950 million.

HEXO Corp. (TSX:HEXO) agreed to acquire US Production Facility In Colorado.

HEXO Corp Receives Control Union Medical Cannabis Standard GACP Certification

Is HEXO (TSE:HEXO) Using Debt In A Risky Way?

Consensus forecasts updated

Second quarter 2021 earnings released: CA$0.17 loss per share (vs CA$4.53 loss in 2Q 2020)

Price target increased to CA$8.46

HEXO Corp. Wins Complete Dismissal of US Federal Shareholder Class Action